Most Recent
Class action firm named in United Petroleum’s suit over ‘evil’ depiction
A law firm running a franchisee class action against United Petroleum has been accused of involvement in a public relations campaign that allegedly damaged the petrol chain’s reputation and depicted it as "evil".
In major trade mark win for a2 Milk, judge finds ‘A2’ not generic
A2 Milk has won a long-running lawsuit alleging Care A2 Plus infringed its trade marks, with a judge finding the infringement was flagrant and rejecting arguments that 'a2' is descriptive of a type of milk that only contains the A2 protein.
‘Heed this caution’: Judge warns parties risk costs for filing irrelevant docs
A judge has hit a container systems company with indemnity costs for tendering hundreds of pages of irrelevant evidence in a trade mark dispute and warned "future litigants that fail to heed this caution" face costs risks.
Medibank slams ‘illogical’ ruling on Deloitte report in data breach class action
Medibank has criticised a judge’s finding that legal professional privilege did not attach to a Deloitte report commissioned in the wake of a massive data breach, arguing she came to an “illogical” conclusion. 
Court upholds IAG’s privilege claim in ASIC discounts case
A judge has upheld IAG’s privilege claim over a technical paper prepared by an actuarial consultant, finding that the report was not merely forwarded to the legal team to cloak it in privilege. 
ASIC fights IAG’s privilege claim in loyalty discounts suit
The corporate regulator is challenging insurer IAG's claims of legal professional privilege over a technical report in proceedings over allegedly misleading loyalty discounts.
Sleeping Duck settles case against former CFO
Melbourne mattress and bedding start-up Sleeping Duck has settled a suit against its former chief financial officer, who has admitted to breaching confidentiality obligations to the company by disclosing information to a competitor.
Zoetis hit with costs in bovine gene patent spat
Zoetis has been ordered to pay Scidera’s costs of defending an unsuccessful summary dismissal application on a lump sum basis in a dispute over a bovine gene patent, with a judge rejecting its “premature” bid for a set-off. 
Sun Pharma defeats appeal over Otsuka’s injectable Abilify patent
The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.
Judge ‘running out of patience’ in Scidera’s bovine gene patent suit
A judge has declined to order US-based animal genomics company Scidera to file a position statement in its bovine gene patent infringement suit and said she was “running out of patience” after unsuccessful strike-out and summary dismissal applications by the defendants.